STAAR Surgical Co reports results for the quarter ended June 30 - Earnings Summary

• STAAR Surgical Co STAA.OQ reported a quarterly adjusted loss of 34 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of 36 cents. The mean expectation of eleven analysts for the quarter was for a loss of 66 cents per share. Wall Street expected results to range from -85 cents to -51 cents per share.

• Revenue fell 55.2% to $44.32 million from a year ago; analysts expected $40.14 million.

• STAAR Surgical Co's reported EPS for the quarter was a loss of 34 cents​.

• The company reported a quarterly loss of $16.81 million.

• STAAR Surgical Co shares had risen by 61.0% this quarter and gained 11.2% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 4.6% in the last three months.​

• In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy," 9 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."

• Wall Street's median 12-month price target for STAAR Surgical Co is $20.00, about 35.1% below its last closing price of $27.02

This summary was machine generated from LSEG data August 6 at 08:57 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)